Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients.
Laracy JC, Yan J, Steiger SN, Tan CA, Cohen N, Robilotti EV, Fender J, Cohen S, Korde N, Lee-Teh M, Noy A, Oved JH, Roeker LE, Shah G, Babady NE, Kamboj M, Seo SK.
Laracy JC, et al. Among authors: cohen s, cohen n.
Haematologica. 2023 Nov 1;108(11):3058-3067. doi: 10.3324/haematol.2023.283015.
Haematologica. 2023.
PMID: 37345467
Free PMC article.